A Safety Study in Participants With Major Depressive Disorder

NCT01155661 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

608

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: LY2216684 (edivoxetine)
DRUG: SSRI

Sponsor

Eli Lilly and Company